Marek Health vs Push Health
Marek Health costs $651 less a month, and both sell semaglutide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Marek Health
Best for: bloodwork inside the monthly price rather than billed on top
Visit Marek Health →
If you are choosing between Marek Health and Push Health, the first difference is cost: Marek Health is $651 a month cheaper at the entry price. Both prescribe semaglutide, so moving from one to the other would not change your drug. Marek Health leads our six-part score, 7.8 to 5.6.
Marek Health vs Push Health price
Marek Health is the cheaper way in: $299 a month against $950 a month at Push Health. That is $651 less each month (69% lower), or about $7,812 over a year of treatment.
Drug by drug: Semaglutide is cheaper at Marek Health ($299 a month vs $950 a month).
Medications and formats
Both sell semaglutide.
On format they match: each offers brand-name pens.
Where each one treats patients
Marek Health lists 50 states, and Push Health does not publish where it ships.
Pricing
Marek Health
Push Health
Ozempic / brand
What each price covers
Marek Health's price also covers the clinician visit, the medication itself, shipping, lab work and coaching, which Push Health does not claim.
Push Health does not say what its price includes.
That matters most for the drug: unless Push Health confirms otherwise, budget for medication on top of its listed price.
Marek Health
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
In the price
Coaching
In the price
Push Health
Inclusions not disclosed.
Where each one scores higher
Overall, Marek Health scores 7.8 and Push Health 5.6 out of 10.
Marek Health is stronger on value (10.0 vs 5.3), trust & safety (5.0 vs 4.0), accessibility (10.0 vs 5.0) and support (10.0 vs 5.0).
Push Health is stronger on user experience (3.0 vs 2.0).
Effectiveness is within half a point.
Marek Health
7.8/10
Push Health
5.6/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Marek Health nor Push Health has an FDA warning letter on record with us.
Features & Coverage
| Feature | Marek Health | Push Health |
|---|---|---|
| Starting Price | ✓$299/mo | $950/mo |
| Features | ✓8 features | 5 features |
| States Available | 50 | Not disclosed |
| Compounded | — | — |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About Marek Health
There is no published rate. Each protocol gets its own quote. Clients in the US are matched to health coaches and partnered physicians for metabolic care, lab panels of some depth, and tirzepatide or semaglutide. Before a client sees a provider the first time, labs must be drawn; testing repeats at 6-12 weeks and then every 6 months. Alongside the partnered physician sits a Marek Health Coach assigned to that client, checking in routinely twice a year.
Read our full Marek Health review →About Push Health
A 55,000+ pharmacy network sits behind Push Health, which writes brand-name GLP-1 prescriptions, Mounjaro, Zepbound, and Ozempic, and routes them through it. The platform is a large US telehealth operation and holds LegitScript certification.
Read our full Push Health review →Pros & Cons
Marek Health
What we like
- Semaglutide costs $299 a month, 70% below the $990 median for brand-name semaglutide across the sellers we compare
- The monthly price includes the medication, clinician visits, shipping, lab work and coaching
- Serves all 50 states
- We found no FDA warning letters issued to Marek Health
- A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake
- Baseline bloodwork is required before a prescription
Watch-outs
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Push Health
What we like
- Semaglutide costs $950 a month, close to the $990 median for brand-name semaglutide across the sellers we compare
- We found no FDA warning letters issued to Push Health
Watch-outs
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Our Verdict
Marek Health wins this one, 7.8 to 5.6, above all for bloodwork inside the monthly price rather than billed on top. It also costs $651 less each month than Push Health. Push Health fits better if semaglutide from $950/month is your priority.
Choose Marek Health if…
You want bloodwork inside the monthly price rather than billed on top and an opening price near $299 a month.
Choose Push Health if…
You want semaglutide from $950/month and an opening price near $950 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
RNK Health
An oral route if you will not self-inject
From $197/mo
Get started →He & She MD
Starting below a standard dose, with microdose tiers
From $99/mo
Get started →Wellorithm
Compounded semaglutide at $247/month
From $247/mo
Get started →Marek Health vs Push Health: FAQ
Close alternatives to Marek Health and Push Health
- Marek Health vs Cost Plus Drugs
- Marek Health vs JumpstartMD
- Marek Health vs Medi-Weightloss
- Marek Health vs Superpower
- Push Health vs JumpstartMD
- Push Health vs Cost Plus Drugs
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.